Skip to main content
Fig. 1 | BMC Pharmacology and Toxicology

Fig. 1

From: The effectiveness of pregabalin with or without agomelatine in the treatment of chronic low back pain: a double-blind, placebo-controlled, randomized clinical trial

Fig. 1

Comparison of the mean outcome measures over the time between the group A (pregabalin & placebo) and group B (pregabalin and agomelatine). (BPI: Brief Pain Inventory; RMDQ: Roland-Morris Disability Questionnaire; SF-36: 36-Item Short Form Survey; HADS: Hospital Anxiety and Depression Scale; GHQ-28: General Health Questionnaire – 28.)

Back to article page

BMC Pharmacology and Toxicology

ISSN: 2050-6511

Contact us